These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Incidence of breakthrough infections after COVID-19 vaccination among the COVID-19 vaccine recipients at a Tertiary Care Hospital in Srinagar. Fazili A; Ain SN; Shah RJ; Raja FN; Farhat D; Nazir I Indian J Public Health; 2023; 67(2):305-308. PubMed ID: 37459029 [TBL] [Abstract][Full Text] [Related]
5. Trends and Correlates of Breakthrough Infections With SARS-CoV-2. Yamal JM; Appana S; Wang M; Leon-Novelo L; Bakota E; Ye Y; Sharma S; Morrison AC; Marko D; Linder SH; Rector A; Jetelina KK; Boerwinkle E; de Oliveira Otto M Front Public Health; 2022; 10():856532. PubMed ID: 35619825 [TBL] [Abstract][Full Text] [Related]
6. High Anti-CoV2S Antibody Levels at Hospitalization Are Associated with Improved Survival in Patients with COVID-19 Vaccine Breakthrough Infection. Heinzl MW; Kolenchery L; Resl M; Klammer C; Black A; Obendorf F; Schinagl L; Feldbauer R; Pohlhammer J; Wagner T; Berger T; Dieplinger B; Clodi M Int J Environ Res Public Health; 2022 Nov; 19(23):. PubMed ID: 36497655 [TBL] [Abstract][Full Text] [Related]
7. The impact of COVID-19 vaccines on the Case Fatality Rate: The importance of monitoring breakthrough infections. di Lego V; Sánchez-Romero M; Prskawetz A Int J Infect Dis; 2022 Jun; 119():178-183. PubMed ID: 35398301 [TBL] [Abstract][Full Text] [Related]
8. Correlates of breakthrough Omicron (B.1.1.529) infections in a prospective cohort of vaccinated patients with rheumatic diseases. Benny L; Mehta P; Ahmed S; Paul A; Sukumaran A; Mohanan M; Vijayan A; Kaveri K; Padmaja R; Shenoy P Rheumatol Int; 2023 Jun; 43(6):1033-1039. PubMed ID: 37029793 [TBL] [Abstract][Full Text] [Related]
10. Factors Associated With COVID-19 Breakthrough Infections in Large Midwestern Healthcare System: Implications for Vulnerable Healthcare Personnel. Rivelli A; Fitzpatrick V; Copeland K; Richards J J Occup Environ Med; 2022 Aug; 64(8):635-641. PubMed ID: 35673248 [TBL] [Abstract][Full Text] [Related]
11. COVID-19 Breakthrough Infection Among Vaccinated Population in the United Arab Emirates. Dash NR; Barqawi HJ; Obaideen AA; Al Chame HQ; Samara KA; Qadri R; Eldesouki S J Epidemiol Glob Health; 2023 Mar; 13(1):67-90. PubMed ID: 36795274 [TBL] [Abstract][Full Text] [Related]
12. Hospitalisation among vaccine breakthrough COVID-19 infections. Juthani PV; Gupta A; Borges KA; Price CC; Lee AI; Won CH; Chun HJ Lancet Infect Dis; 2021 Nov; 21(11):1485-1486. PubMed ID: 34506735 [No Abstract] [Full Text] [Related]
13. SARS-CoV-2 Breakthrough Infections after introduction of 4 COVID-19 Vaccines, South Korea, 2021. Yi S; Choe YJ; Kim J; Kim YY; Kim RK; Jang EJ; Lim DS; Byeon HR; Lee S; Park E; Kim SJ; Park YJ Emerg Infect Dis; 2022 Mar; 28(3):753-756. PubMed ID: 35202529 [TBL] [Abstract][Full Text] [Related]
14. A systematic review of Vaccine Breakthrough Infections by SARS-CoV-2 Delta Variant. Zhang M; Liang Y; Yu D; Du B; Cheng W; Li L; Yu Z; Luo S; Zhang Y; Wang H; Zhang X; Zhang W Int J Biol Sci; 2022; 18(2):889-900. PubMed ID: 35002532 [TBL] [Abstract][Full Text] [Related]
16. Vaccine-breakthrough SARS-CoV-2 infections in people with multiple sclerosis and related conditions: An observational study by the New York COVID-19 Neuro-Immunology Consortium (NYCNIC-2). Klineova S; Farber RS; DeAngelis T; Leung T; Smith T; Blanck R; Zhovtis-Ryerson L; Harel A Mult Scler; 2023 Jul; 29(8):990-1000. PubMed ID: 37431628 [TBL] [Abstract][Full Text] [Related]
17. Risk factors for severe Covid-19 breakthrough infections: an observational longitudinal study. Ben Fredj S; Ghammem R; Zammit N; Maatouk A; Haddad N; Haddad N; Kachroudi M; Rebai S; Laadhari H; Ghodhbani MM; Maatoug J; Ghannem H BMC Infect Dis; 2022 Nov; 22(1):894. PubMed ID: 36443699 [TBL] [Abstract][Full Text] [Related]